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A B S T R A C T
Aim: To investigate whether exposure to dampness and mold at home and at work induce sleep disturbances and
daytime sleepiness among adults.
Materials and methods: Associations between onset of sleep disturbances and dampness, mold and mold odor at
home and at work were investigated in a cohort of 11,318 adults from the population in Iceland, Norway,
Sweden, Denmark and Estonia. The participants answered a questionnaire at baseline and 10 years later, with
questions on sleep disturbances, including difficulty initiating sleep (DIS), difficulty maintaining sleep (DMS),
early morning awakening (EMA), insomnia symptoms, snoring and excessive daytime sleepiness (EDS). Multiple
logistic regression models were applied to estimate associations adjusting for potential confounders including
gender, age, smoking habit at baseline, change of smoking habit from baseline to follow up, BMI at baseline,
change of BMI from baseline to follow up, education level at follow up, allergic rhinitis at baseline, doctor
diagnosed asthma at baseline and chronic bronchitis at baseline.
Results: Baseline floor dampness, visible mold and mold odor at home increased onset of DIS, DMS, EMA, in-
somnia symptoms and snoring during follow up (OR 1.29–1.87). Any sign of dampness at baseline increased
onset of DIS (OR 1.28, 95%CI 1.06–1.55), DMS (OR 1.17, 95%CI 1.02–1.34) and insomnia symptoms (OR 1.18,
95%CI 1.03–1.36). Dampness at home during follow up increased onset of DIS, DMS, EMA, insomnia symptoms
and EDS (OR 1.17–1.36). Dampness at work during follow up increased onset of DIS, EMA, insomnia symptoms
and EDS (OR 1.16–1.34). Combined dampness at home and at work during follow up increased the risk of onset
of DIS, DMS, EMA, insomnia symptoms and EDS (OR 1.29–1.74).
Conclusions: Dampness and mold at home and at work can increase the development of insomnia symptoms,
snoring and EDS among adults.
1. Introduction
A good night sleep is critical for health and wellbeing. Insomnia is
the most common sleep disorder. Most studies have focused on three
forms of insomnia symptoms: difficulty initiating sleep, difficulty
maintaining sleep and early morning awakening (Buysse, 2013). One
review concluded that about one third of the general population suffer
from at least one insomnia symptom (Ohayon, 2002) and recent studies
have reported that 6–16% of the population in European countries have
been diagnosed with insomnia (Riemann et al., 2017). Obstructive sleep
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apnea (OSA), characterised by loud habitual snoring and breathing
pauses during sleep, is a worldwide highly prevalent disease with
arousals during sleep followed by excessive daytime sleepiness, im-
pairment of neurocognitive function and reduced daytime performance
(Marin-Oto et al., 2019; Gislason et al., 2016; Franklin and Lindberg,
2015). Previous studies indicate that women suffer more often from
insomnia but men suffer more often from OSA (Ohayon, 2002; Franklin
and Lindberg, 2015; Bartlett et al., 2008).
Sleep disorders can increase sick leave (Riemann et al., 2017;
Theorell-Haglow et al., 2006) and reduce quality of life (Moreno-Vecino
et al., 2017; Effati-Daryani et al., 2017). Sleep problems are more
common among older individuals (Ohayon, 2002; Bartlett et al., 2008)
and smokers (Franklin et al., 2004; Nakata et al., 2008; Morioka et al.,
2018). Sleep disorders can increase the risk of getting a number of
important diseases. Common chronic diseases like cardiovascular dis-
eases, chronic obstructive lung diseases and diabetes were all associated
with sleep disturbances including insomnia, snoring, daytime sleepiness
or OSA (Riemann et al., 2017; Marin-Oto et al., 2019; Owens et al.,
2017). Increased risk of cardio-metabolic diseases (Cappuccio and
Miller, 2017; Hoyos et al., 2017) and cancer (Shi et al., 2020) were
found among people with sleep disorders. Recent studies also reported
sleep disorders in relation to neurological disorders, including cognitive
impairment and dementia (Riemann et al., 2017; Wennberg et al.,
2017). Moreover, individuals with rhinitis (Young et al., 1997) and
obesity (Cai et al., 2018; Palm et al., 2015) have more sleep disorders
such as insomnia, snoring or excessive daytime sleepiness. Weight gain
can be a risk factor for development of insomnia (Cai et al., 2018; Palm
et al., 2015), snoring (Cai et al., 2018) and daytime sleepiness (Palm
et al., 2015).
Noise is the most commonly investigated environmental risk factor
for impaired sleep quality. Studies from Norway, Finland and Canada
have demonstrated negative impact of traffic noise on insomnia or sleep
disturbances among adults (Evandt et al., 2017; Halonen et al., 2012;
Perron et al., 2016). There are few studies on indoor environment and
sleep disturbances. Studies from Japan found that environmental to-
bacco smoke was associated with insomnia symptoms and insufficient
sleep among pregnant women (Ohida et al., 2007) and adolescents
(Morioka et al., 2018). Studies from Netherlands, Denmark and China
showed that insufficient building ventilation can impair sleep quality
among adults (Mishra et al., 2018; Strom-Tejsen et al., 2016; Wei et al.,
2017).
Dampness and mold at home is the most well documented indoor
risk factor for respiratory illnesses (WHO, 2009). Several studies from
Europe showed that residential dampness increased incidence of
asthma and rhinitis among adults (Wang et al., 2019; Gunnbjornsdottir
et al., 2006; Jaakkola et al., 2002). However, few studies exist on as-
sociations between dampness and mold and sleep disturbances. Two
cross-sectional studies reported associations between living in damp
buildings and insomnia/sleep problems in adults (Packer et al., 1994;
Janson et al., 2005).
There are less studies available on indoor environmental risk factors
for adult snoring. Environmental tobacco smoke was found to be as-
sociated with snoring among adults in Northern Europe and Japan
(Franklin et al., 2004; Ohida et al., 2007). One study from Turkey
showed that exposure to biomass smoke was associated with snoring
and observed apnea among adults (Ekici et al., 2008). We found no
studies on dampness/mold and snoring. There are no previous long-
itudinal cohort studies on onset of insomnia or snoring among adults in
relation to dampness and mold.
Our aim was to investigate whether indoor dampness, mold and
mold odor at home and at work increases insomnia symptoms, snoring
and excessive daytime sleepiness during a 10 year follow up in the
Respiratory Health in Northern Europe (RHINE) study. A population
based cohort of adults (Wang et al., 2019).
2. Materials and methods
2.1. Ethics statement
This study was conducted with the approval from the appropriate
ethics board at each centre. All participants gave informed consent
prior to participation.
3. Study design and target population
The RHINE II study is a postal questionnaire follow up of subjects
from seven centres in five Nordic countries from the European
Community Respiratory Health Survey stage I (ECRHS I) performed in
1989–1992. The seven centres include Reykjavik in Iceland, Bergen in
Norway, Umeå, Uppsala and Gothenburg in Sweden, Aarhus in
Denmark and Tartu in Estonia. In the ECRHS I study, 3000–4000 sub-
jects (20–44 y) were randomly selected from each centre through na-
tional population registers. A postal questionnaire was then sent to
those subjects.
In total, 21,659 subjects participated in ECRHS I (response rate
86%) (Johannessen et al., 2014). The participants in RHINE II received
a postal follow up questionnaire in 1999–2000. The RHINE II ques-
tionnaire included questions on sleep disturbances, respiratory health
and the indoor environment at home and at work. The RHINE II par-
ticipants (n = 15,990) were invited to join a second follow up (RHINE
III) in 2010–2012, with identical questions on sleep disturbances as in
RHINE II. Totally 11,318 participated in RHINE II and RHINE III (re-
sponse rate 71%) (Fig. 1). Participation was defined as answering at
least one of five questions on sleep disturbances (DIS, DMS, EMA, in-
somnia symptoms, snoring and EDS, see detailed description below).
RHINE II is defined in the present article as the baseline study and the
RHINE III as the follow up.
Fig. 1. The flow-chart of the study design.
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3.1. Assessment of sleep disturbances
Sleep disturbances in the last months were estimated using a five-
point scale according to the Basic Nordic Sleep Questionnaire (Partinen
and Gislason, 1995): never, less than once a week, 1–2 nights/days per
week, 3–5 nights/days per week, and almost nightly/daily. Difficulty
initiating sleep (DIS) was defined as having trouble falling asleep in the
evening at least three nights per week. Difficulty maintaining sleep
(DMS) was defined as waking up several times during the night at least
three nights per week. Early morning awakening (EMA) was defined as
waking up early in the morning and being unable to go back to sleep at
least three nights per week. Insomnia symptoms was defined as having
at least one of DIS, DMS or EMA. Habitual snoring was defined as re-
porting loud and disturbing snoring at least three nights per week.
Excessive daytime sleepiness (EDS) was defined as having problems
with feeling drowsy or sleepy during the daytime at least three days per
week. The questionnaire used at baseline and follow up had the same
questions on sleep disturbances. Our well-established questions on sleep
disturbances have been used in other international studies (Bengtsson
et al., 2017; Mindus et al., 2018).
Onset of a particular symptom such as DIS, DMS, EMA, insomnia
symptoms, snoring and EDS was defined as not reporting the particular
symptom at baseline but reporting the particular symptom at follow up
(Gunnbjornsdottir et al., 2006).
3.2. Assessment of indoor dampness, mold and mold odor
Four questions were asked at baseline about the following signs of
dampness in the home environment in the last 12 months (Response
options: Yes/No):
(1) “Water leakage or water damage indoors on walls, floors or ceilings
(‘water damage’)”;
(2) “Bubbles or yellow discoloration on plastic floor covering or black
discoloration of parquet floor (‘floor dampness’)”;
(3) “Visible mold growth indoors on walls, floors or ceilings (‘visible
mold’)”;
(4) “Mold odor in one or several rooms other than the cellar (mold
odor)”;
The variable “any dampness” was defined as answering yes on
question (1), (2) or (3) above.
Two questions asked about home and workplace exposure to
dampness during the follow up period (Response options: Yes/No):
(1) “Any dampness damage, water leakage or visible mold at home
during the past 10 years (‘dampness or mold at home during follow
up’)”;
(2) “Any dampness damage, water leakage or visible mound in the
workplace building during the past 10 years (‘dampness or mold at
work during follow up’)”.
Based on the two questions on home and work dampness or mold
during follow up, a categorized variable with four alternatives was
created: no dampness or mold, dampness or mold at home only,
dampness or mold at work only, and dampness or mold both at home
and at work.
3.3. Other independent variables
Information on gender, age, height, weight, asthma, rhinitis and
chronic bronchitis were obtained from the baseline data. Body mass
index (BMI) was calculated from self-reported height and weight (kg/
m2) both at baseline and at follow up. Change of BMI from baseline to
follow up was calculated. Education level (primary school/high school/
university education) was only available at follow up. There were
information on smoking habits (never/ever smokers/current smokers)
both at baseline and follow up. Change of smoking habit from baseline
to follow up (no change/start smoking/stop smoking) was calculated.
Asthma was defined as a positive answer to both of these two
questions: “Do you have or have you ever had asthma?” and “Have you
ever had asthma diagnosed by a doctor?”. Allergic rhinitis was defined
as a positive answer to the question: “Do you have any nasal allergies
including hayfever?”. Chronic bronchitis was defined as positive an-
swers to all three of the following questions: “Do you usually bring up
phlegm or do you have phlegm in your airways which you have diffi-
culty bringing up?”, “Do you bring up phlegm in this way almost daily
at least three months every year?”, and “Have you had this kind of
problem for at least two years in a row?”. Based on these questions,
doctor diagnosed asthma, allergic rhinitis and chronic bronchitis at
baseline and at follow up were created, respectively. Moreover, onset of
doctor diagnosed asthma, onset of allergic rhinitis and onset of chronic
bronchitis based on baseline and follow up data were created.
3.4. Statistical analysis
The analysis strategy in the present study including: firstly, in-
vestigating associations between dampness and mold exposure at
baseline and onset of sleep disturbances; secondly, investigating asso-
ciations between dampness or mold exposure during follow up col-
lected retrospectively and onset of sleep disturbances.
We used Stata 15.1 (Stata Corporation, College Station, Texas,
USA). Two level (centre, individual) logistic regression models were
created to estimate associations between dampness indicators at base-
line or during follow up and onset of sleep disturbances (DIS, DMS,
EMA, insomnia symptoms, snoring and EDS), adjusting for gender, age,
smoking habit at baseline, change of smoking habit from baseline to
follow up, BMI at baseline, change of BMI from baseline to follow up,
education level at follow up, doctor diagnosed asthma at baseline, al-
lergic rhinitis at baseline and chronic bronchitis at baseline. Moreover,
associations between combinations of dampness and mold at home and
at work during follow up (categorized as none, at home, at work or
both) and onset of sleep disturbances were estimated using similar lo-
gistic regression models. Similar logistic regression models were ap-
plied with extra adjustment of onset of doctor diagnosed asthma, onset
of allergic rhinitis and onset of chronic bronchitis. In order to detect
heterogeneity between centres on association between dampness and
onset of insomnia, the adjusted OR was calculated separately in each
centre. An average effects estimate was derived, and potential hetero-
geneity between centres was examined (p < 0.1) using standard
methods for random effects meta-analysis. Associations were expressed
as odds ratios (OR) with a 95% confidence interval (CI).
4. Results
Totally 11,318 subjects who participated both at baseline and
follow up were included. The mean follow up time was
11.3 ± 1.1 years. Among the participants 54.3% were females, 26.1%
current smokers and 26.4% were ex-smokers at baseline. Moreover,
7.9% had doctor diagnosed asthma, 23.5% had allergic rhinitis and
6.5% had chronic bronchitis at baseline. A total of 248 (2.4%) parti-
cipants started smoking and 1248 (12.0%) participants stopped
smoking during follow up. The mean age ± SD of the participants was
40 ± 7.3 years at baseline. Nonparticipants in RHINE III had slightly
higher prevalence of all sleep disturbances except DMS in RHINE II as
compared to participants (Table 1). However, the prevalences of
dampness indicators at home at baseline (RHINE II) were similar among
participants and nonparticipants in RHINE III (Table 1).
In total 2457 (29.2%) participants had new onset of insomnia
symptoms. Among the three insomnia symptoms, onset of DMS was
most common (n = 2210, 24.3%), followed by EMA (n = 1206,
11.8%), and the least common was DIS (n = 876, 8.4%). A total of
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1359 (15.7%) participants had new onset of snoring and 1204 (13.8%)
participants had new onset of EDS. Reykjavik had the highest onset rate
for DIS, snoring and EDS, and Umeå had the highest onset rate for DMS,
EMA and insomnia symptoms (Table 2, centres were ordered by lati-
tude).
Water damage (13.3%) and visible mold (6.7%) were common at
baseline (Table 3, centres were ordered by latitude). During follow up,
25.3% of the participants reported dampness or mold at home in cur-
rent or previous home in the past 10 year, and 19.5% reported damp-
ness or mold in the current or previous workplace building in the past
10 years. Tartu had the highest prevalence of all dampness indicators
(at home or at work), except floor dampness. Reykjavik had highest
prevalence of floor dampness. Totally 8.0% had dampness or mold both
at home and at work, 17.2% reported dampness or mold only at home
and 11.5% only at work.
Onset of sleep disturbances in relation to dampness and mold are
shown in Table 4. Floor dampness at home at baseline was related to
onset of DIS, DMS, EMA and insomnia symptoms (OR = 1.53–1.87).
Visible mold at home at baseline was associated with onset of DIS, DMS,
insomnia symptoms and snoring (OR = 1.30–1.52). Mold odor at home
at baseline was associated with DIS (OR = 1.67). Any dampness at
home at baseline was related to DIS, DMS and insomnia symptoms
(OR = 1.17–1.28). Dampness or mold at home during follow up was
associated with onset of DIS, DMS, EMA, insomnia symptoms and EDS
(OR = 1.17–1.36). Moreover, dampness or mold in the workplace
building during follow up was related to onset of sleep disturbances,
including onset of DIS, EMA, insomnia symptoms and EDS
(OR = 1.16–1.34).
Table 1
Sleeping disturbances and dampness indicators in RHINE II among participants and nonparticipants in RHINE III.
Participants in RHINE III Nonparticipants in RHINE III p
Subjects n n = 11,318 n = 4672
Sleeping disturbances RHINE II Difficulty initiating sleep (DIS) 6.9 10.1 <0.001
Difficulty maintaining sleep (DMS) 18.6 19.4 0.216
Early morning awakening (EMA) 8.5 10.0 0.002
Insomnia symptoms a 24.2 26.9 <0.001
Snoring 17.9 19.4 0.036
Excessive daytime sleepiness (EDS) 21.4 23.0 0.022
Dampness RHINE II Water damage 13.3 13.7 0.515
Floor dampness 3.9 3.7 0.745
Visible mold 6.7 6.8 0.696
Mold odor 3.5 3.8 0.328
Any dampnessb 17.8 18.2 0.554
a Insomnia symptoms was defined as reporting at least one of the three symptoms including difficulty initiating sleep, difficulty maintaining sleep and early
morning awakening.
b Any dampness was defined as water damage, floor dampness or visible mold in the last 12 months at baseline.
Table 2
Onset over the study period of sleeping disturbances in different centres ordered by latitude (%) (n = 11,318).
Reykjavik (%) Umeå (%) Bergen (%) Uppsala (%) Tartu (%) Gothenburg (%) Aarhus (%) Total (%)
Onset Difficulty initiating sleep (DIS) 10.4 8.5 9.7 7.9 8.1 9.8 5.4 8.4
Difficulty maintaining sleep (DMS) 24.9 27.1 21.2 26.5 22.7 26.9 21.6 24.3
Early morning awakening (EMA) 11.6 13.4 10.0 12.5 13.1 12.7 10.4 11.8
Insomnia symptomsa 30.3 32.8 25.7 31.7 26.9 31.1 26.3 29.2
Snoring 20.3 15.3 14.1 16.6 15.1 16.1 13.3 15.7
Excessive daytime sleepiness (EDS) 16.1 13.9 14.8 13.8 10.7 12.9 13.4 13.8
a Insomnia symptoms was defined as reporting at least one of the three symptoms including difficulty initiating sleep, difficulty maintaining sleep and early
morning awakening.
Table 3
Prevalence of signs of indoor dampness and mold at home and in the workplace building in seven centres ordered by latitude (%) (n = 11,318).
Reykjavik (%) Umeå (%) Bergen (%) Uppsala (%) Tartu (%) Gothenburg (%) Aarhus (%) Total (%)
Baseline Water damage 20.0 10.0 13.4 8.9 23.5 8.0 13.4 13.3
(at home) Floor dampness 6.7 5.7 2.2 4.0 3.0 4.2 1.5 3.9
Visible mold 6.1 3.9 4.7 6.4 13.0 4.6 9.8 6.7
Mold odor 4.9 2.5 2.3 3.2 5.9 2.4 4.3 3.5
Any dampness a 22.7 14.1 16.4 15.0 31.7 12.4 17.9 17.8
Follow up Dampness or mold at home
during follow up
32.8 21.0 24.8 23.2 34.4 20.9 24.0 25.3
Dampness or mold in the
workplace building during
follow up
22.3 21.0 17.4 23.5 24.0 19.5 11.6 19.5
Combined dampness or mold
during follow up
None 57.2 64.6 65.1 61.3 53.3 66.9 70.0 63.3
Only at home 20.7 14.4 17.6 15.4 22.6 13.5 18.5 17.2
Only at work 10.4 14.4 10.1 15.6 12.3 12.2 6.1 11.5
Both 11.8 6.6 7.2 7.7 11.8 7.4 5.4 8.0
a Any dampness was defined as water damage, floor dampness or visible mold in the last 12 months at baseline.
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Associations between dampness or mold during follow up (four
categories: none, n = 6993; only at home, n = 1905; only at work,
n = 1271; and both, n = 880) and onset of sleep disturbances are
shown in Table 5. Exposure to dampness or mold both at home and at
work during follow up had the strongest associations with onset of DIS,
DMS, EMA, insomnia symptoms and EDS (OR 1.29–1.74). Extra ad-
justment including onset of doctor diagnosed asthma, onset of allergic
rhinitis and onset of chronic bronchitis showed similar associations
(Tables S1 and S2).
Meta-analysis was used to detect heterogeneity between the centres
(Fig. 2, Fig. S1 and S2). The estimates from meta-analyses were almost
identical to those derived when analysing the pooled data by multilevel
logistic regression. There was no significant centre heterogeneity be-
tween any dampness at home at baseline and onset of insomnia
symptoms (Fig. 2). No significant centre heterogeneity was found be-
tween dampness or mold at home during follow up and onset of in-
somnia symptoms (Fig. S1). In contrast, significantly centre hetero-
geneity was found between dampness or mold at work during follow up
and onset of insomnia symptoms (Fig. S2). The strongest associations
were found in Gothenburg and Tartu.
5. Discussion
This is the first prospective study on onset of sleep disturbances in a
population-based samples of adults in Nordic countries. The main
finding was that the risk to develop sleep disturbances were more
common in subjects living in damp houses or working in damp build-
ings. Dampness and mold at home at baseline increased onset of in-
somnia symptoms and snoring. Moreover, dampness or mold at home
during follow up was related to onset of insomnia symptoms and EDS.
Furthermore, our study found that dampness or mold at work during
follow up was associated with onset of sleep disturbances, including
insomnia symptoms and EDS. Combined dampness or mold at home
and at work during follow up showed the strongest associations with
onset of DIS, DMS, EMA, insomnia symptoms and EDS.
Nearly one third of the participants had developed insomnia
symptoms (any of the three insomnia symptoms) during 10 years of
follow up, and one fourth of the participants suffered from new onset of
DMS at follow up. Moreover, onset of snoring (15.7%) and EDS (13.8%)
were also common.
The observed association between damp and moldy buildings and
onset of sleep disturbances is a novel finding. We found only two pre-
vious studies reporting associations between prevalence of sleep pro-
blems among adults and building dampness, none of them were long-
itudinal (Packer et al., 1994; Janson et al., 2005). One study from
England reported that damp housing was related to impaired sleep
(Packer et al., 1994). However, questions regarding sleep and damp
housing in that study were not as detailed as in our study. A previous
prevalence study from Northern Europe reported that water damage,
visible mold and floor dampness were associated with insomnia, and
the association was strongest between floor dampness and insomnia
(Janson et al., 2005).
Our study found that floor dampness was related to higher onset of
DIS, DMS, EMA and insomnia symptoms. Among all types of dampness
indicators at baseline, floor dampness had the most associations with
onset of sleep disturbances. Dampness in the concrete floor construction
is common in Northern Europe. One explanation can be that the con-
crete becomes wet during building process. This type of floor con-
struction can cause chemical degradation of di-ethyl-hexylphtalate
(DEHP) used in PVC materials or acrylate-polymers in water based floor
glues. The degradation process causes emission of 2-ethyl-1-hexanol to
the indoor environment. Previous studies from Northern Europe have
reported that dampness in the floor construction was the dampness
indicator with the strongest association with prevalence of asthma
(Norback et al., 1999) and prevalence of insomnia (Janson et al., 2005).
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symptoms, nasal inflammation (Wieslander et al., 2010) and asthma
symptoms (Norback et al., 2000).
Visible mold was associated with onset of DIS, DMS, insomnia
symptoms and snoring in the present study. An association between
visible mold and prevalence of insomnia has been reported in one
previous study (Janson et al., 2005). Presence of visible mold is not
common in Nordic countries due to the cold and dry climate.
Mold odor was related to increased onset of DIS in our study. Fungi
and bacteria can cause emission of microbial volatile organic com-
pounds (MVOC) during their metabolic processes (Korpi et al., 2009).
Some of MVOC compounds have a typical moldy or pungent smell.
Higher level of MVOC at home were found to be associated with mucus
membrane symptoms among adults (Sahlberg et al., 2013; Araki et al.,
2010). Moreover, reported mildew odor at home was associated with
impaired sleep among adults in America (Shiue, 2015).
We further found that the combined effect of dampness/mold at
home and at work had the highest impact on the onset of DIS, DMS,
EMA, insomnia symptoms and EDS. Our study is the first study in-
vestigating combined dampness/mold at home and at work in relation
to sleep disturbances among adults.
The meta-analyses showed significant centre heterogeneity between
dampness/mold at work during follow up and onset of insomnia
symptoms. This indicates that there can be differences in dampness in
workplace buildings in relation to the risk of onset of insomnia. More
detailed studies on type of dampness in workplace are needed in future
studies.
5.1. Potential biological explanations to the associations
The biological mechanism for dampness/mold and impairment of
sleep is not clear. A humid indoor environment, with signs of dampness,
benefits growth of house dust mites and microorganisms such as mold
and bacteria. Previous studies have showed associations between
dampness and mold in association with adverse respiratory health ef-
fects (Fisk et al., 2007; Quansah et al., 2012; Jaakkola et al., 2013). We
therefore adjusted for doctor diagnosed asthma, allergic rhinitis and
chronic bronchitis at baseline in the analysis. The associations between
building dampness and sleep disturbances remained significant after
adjusting for those respiratory disorders, indicating that the effects of
dampness and mold on sleep quality is mainly mediated by other me-
chanisms than induction of respiratory illnesses.
One possible explanation is that damp and moldy environment may
cause irritation and inflammation in mucus membrane or airways. One
main mold cell wall component, β-1,3-glucan, was reported to cause
airway inflammation (Thorn and Rylander, 1998) and fatigue (Wan and
Li, 1999). Working in mold contaminated buildings has found to be
associated with adult nasal inflammation (Hirvonen et al., 1999;
Wieslander et al., 2007; Walinder et al., 2001). Nasal obstruction is a
Table 5
Associations between onset of sleeping disorders and dampness or mold during follow up (four categories: none, at home, at work and both). Adjusted odds ratio (OR)
with 95% confidence intervals (CI) (n = 11,318).
None (n = 6993) Only at home (n = 1905) Only at work (n = 1271) Both (n = 880)
Onset of difficulty initiating sleep (DIS) 1.00 1.07(0.86,1.33) 1.12(0.87,1.43) 1.74(1.35,2.25) ***
Onset of difficulty maintaining sleep (DMS) 1.00 1.25(1.08,1.45) ** 1.13(0.95,1.34) 1.30(1.06,1.59) *
Onset of early morning awakening (EMA) 1.00 1.13(0.94,1.35) 1.24(1.01,1.52) * 1.52(1.21,1.92) ***
Onset of insomnia symptoms 1.00 1.16(1.01,1.34) * 1.14(0.97,1.34) 1.29(1.05,1.57) *
Onset of snoring 1.00 1.08(0.90,1.28) 0.90(0.73,1.13) 1.21(0.96,1.54)
Onset of excessive daytime sleepiness (EDS) 1.00 1.33(1.11,1.58) ** 1.23(0.99,1.53) 1.60(1.26,2.03) ***
Two level logistic regression models (centre, individual), adjusted for age (baseline), gender (baseline), smoking (baseline), change of smoking habit from baseline to
follow up, BMI (baseline), change of BMI from baseline to follow up, education level (follow up), doctor diagnosed asthma (baseline), allergic rhinitis (baseline) and
chronic bronchitis (baseline).
*** p < 0.001, **p < 0.01, *p < 0.05.
Fig. 2. Adjusted odds ratios and 95% CIs of in-
somnia symptoms in subjects living in homes with
any dampness at baseline with a combined odds
ratio (diamond indicates 95% CI) from the model
with centre as the random effect. The model was
adjusted for age (baseline), gender (baseline),
smoking (baseline), change of smoking habit from
baseline to follow up, BMI (baseline), change of
BMI from baseline to follow up, education level
(follow up), doctor diagnosed asthma (baseline),
allergic rhinitis (baseline) and chronic bronchitis
(baseline).
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well-known risk factor for sleep disturbances (Bengtsson et al., 2015;
Hellgren et al., 2007). Moreover, odors can lead to unpleasant per-
ceptions (sensory impairment) during sleep causing sleep disturbances.
Studies from Sweden and Japan have demonstrated that higher level of
MVOC compounds can be related to mucous membrane symptoms
(Sahlberg et al., 2013; Araki et al., 2010). Indoor dampness can cause
mold growth as well as chemical degradation of building materials,
causing emission of VOC compounds (Walinder et al., 2001; Wieslander
et al., 1999). VOC emissions in moisture damaged buildings can be
related to nasal mucosal swelling and inflammation (Wieslander et al.,
2010; Wieslander et al., 1999). It has been suggested that insufficient
ventilation flow can influence cerebral blood flow which can trigger
migraine during sleep and in turn impair sleep quality among occupants
with migraine (Schwarzberg, 1993). Some other environmental factors
may have similar impacts on sleep quality.
5.2. Strengths and limitations
Our study is the first longitudinal study investigating dampness and
mold in relation to adult onset of sleep disturbances in several coun-
tries. Our results are less likely to be influenced by selection bias since
the participation rate in the initial ECRHS I postal questionnaire was
high (86%) (Johannessen et al., 2014) and the participation rate from
RHINE II to RHINE III was reasonable (71%). Most dampness indicators
were assessed at baseline to avoid recall bias, which diminishes the
likelihood of reverse causality. There is a large amount of evidence
indicating negative effects of building dampness on respiratory dis-
orders (Fisk et al., 2007; Quansah et al., 2012; Jaakkola et al., 2013).
We therefore adjusted for respiratory disorders, including doctor di-
agnosed asthma, allergic rhinitis and chronic bronchitis in our study
(extra adjustment of onset of these symptoms in one additional model).
Moreover, smoking habits and education level were adjusted for in the
analyses. Thus, our results are less likely to be affected by selection or
information bias, or be due to other factors related to low socio-
economic status.
Our study has some limitations. It was performed in a limited geo-
graphic area (Northen Europe), characterized by cold climate and lack
of daylight in winter due to short days. The cold climate is linked to less
dampness and indoor mold as compared to warmer climate zones in
Europe (Norback et al., 2017). The lack of daylight in winter can cau-
se depressive symptom in subjects with seasonal affective disorder
(Kurlansik and Ibay, 2012), but it is unclear how seasonal variation of
daylight affects insomnia in the general population in northern Europe.
One population study from Norway found that lack of daylight in-
creased difficulties with falling asleep and daytime fatigue (Friborg
et al., 2012) but another Norwegian population study found no seasonal
variation of insomnia (Sivertsen et al., 2011). Ventilation can be worse
in damp buildings with visible mold growth and mold odor. Studies
from Denmark and Finland have reported decreased ventilation in as-
sociation with increased daytime sleepiness (Strom-Tejsen et al., 2016;
Vehvilainen et al., 2016). Unfortunately, we had no data on ventilation
flow in the homes. Moreover, other possible environment risk factors
for sleep disorders such as traffic noise, cooking fumes, biomass smoke,
environmental tobacco smoke and illumination were not adjusted for in
our study. However, these factors are less likely to be associated with
building dampness, and are therefore unlikely confounders.
6. Conclusions
Dampness and mold at home and at work increase the risk for sleep
disturbances, including insomnia symptoms, snoring and EDS, espe-
cially with the combined exposure for both dampness and mold at home
and at work. Floor dampness was the strongest risk factor for DIS, EMA
and insomnia symptoms. This study further emphasizes the importance
of reducing indoor dampness and mold both at home and at work due to
the risk of impairing sleep quality. Further studies from other
geographical areas are needed on this topic.
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